Side effect profile of interferon beta-1b in MS: results of an open label trial

Neurology
L K NeilleyS L Hauser

Abstract

To determine which patients are prone to side effects from interferon beta-1b and which side effects are most troublesome, we studied 72 patients with clinically definite MS who were started on interferon beta-1b after its release and found that the side effects significantly associated with treatment included skin reactions, flu-like symptoms, fatigue, leukopenia, new or worsened depression, and new or worsened headache. Of these, only fatigue and depression were significantly associated with discontinuance of therapy. Moreover, the course of disease before initiation of treatment also had a significant impact on the likelihood of discontinuing medication. Thus, despite an apparently similar therapeutic benefit (as judged by the similarly reduced attack rate in each group), patients with a secondary chronic progressive course were more likely to discontinue treatment (63%) than patients with either a relapsing/progressive course (18%) or a remitting/relapsing course (7%). Indeed, in the final regression equation, the only factors significantly related (r = 0.875) to the discontinuance of therapy were fatigue (p < 0.0001), a fatigue-depression interaction (p < 0.0001), and a chronic progressive course of disease (p<0.0001). Thu...Continue Reading

Citations

Mar 20, 2001·Journal of Clinical Psychology·D C Mohr, D Cox
Jun 15, 2006·Journal of Neurology·N TéllezX Montalban
Mar 20, 2002·Current Neurology and Neuroscience Reports·L B Krupp, C Christodoulou
Dec 7, 2007·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Bruce J DiamondLinda Graves
May 17, 2005·Physical Medicine and Rehabilitation Clinics of North America·William S MacAllister, Lauren B Krupp
Mar 4, 1999·Journal of the Neurological Sciences·L DurelliG Aimo
Aug 22, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Martin SchaeferKlaus Lieb
Oct 10, 2012·The Pharmacogenomics Journal·V Foti CuzzolaS Marino
Mar 25, 2011·The Clinical Neuropsychologist·Kathryn Holden, Claire L Isaac
Apr 30, 2005·Journal of Palliative Medicine·C S BerkmanN J Holland
Apr 25, 2006·Journal of Clinical Gastroenterology·Gregory M Asnis, Richard De La Garza
Mar 5, 2008·International Journal of Nursing Practice·David LeeAnnie Topping
Nov 19, 2008·Health and Quality of Life Outcomes·Olympia HadjimichaelUNKNOWN North American Research Committee on Multiple Sclerosis
Jun 8, 2001·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·D C MohrD E Goodkin
Dec 4, 2004·Sports Medicine·Lesley J White, Rudolph H Dressendorfer
Mar 14, 2008·CNS Drugs·Walter Pöllmann, Wolfgang Feneberg
Apr 9, 2014·Journal of Neuroinflammation·Carolyn A ThomsonGerard J Graham
Sep 4, 2009·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Loredana La Mantia
Sep 2, 1998·Current Opinion in Neurology·A J Thompson
Apr 1, 2012·International Journal of MS Care·Sonya KimVance Zemon
Oct 15, 2010·The International Journal of Neuroscience·Maria MelansonMichael Namaka
Mar 17, 2007·Seminars in Ophthalmology·Reid LongmuirJacinthe Rouleau
Mar 20, 2014·Cutaneous and Ocular Toxicology·Pinar OzuguzCigdem Tokyol
Aug 1, 1997·Mayo Clinic Proceedings·S F HunterJ H Noseworthy
Jul 2, 2010·Trends in Molecular Medicine·Marco Prinz, Ulrich Kalinke
Oct 6, 2009·Progress in Neurobiology·Nathalie KoningRobert M Hoek
Dec 26, 2015·Survey of Ophthalmology·Christopher Eckstein, M Tariq Bhatti
Apr 14, 2009·Revue neurologique·C Lebrun, M Cohen
Oct 17, 2007·The Psychiatric Clinics of North America·Lydia A Chwastiak, Dawn M Ehde
Mar 27, 2007·Journal of the Neurological Sciences·X Montalban
Oct 19, 2004·Journal of Affective Disorders·Jennifer M Loftis, Peter Hauser
May 12, 2005·Physiology & Behavior·Marion U GoebelManfred Schedlowski

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.